MétaCan
Menu
Back to cohort
Record W3020842424 · doi:10.14745/ccdr.v40is3a02

(CAEFISS) Annual report for vaccines administered in 2012

2014· article· en· W3020842424 on OpenAlexafffundvenueabout
BJ Law, J Laflèche, N Ahmadipour, H Anyoti

Bibliographic record

VenueCanada Communicable Disease Report · 2014
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmacovigilance and Adverse Drug Reactions
Canadian institutionsPublic Health Agency of Canada
FundersPublic Health AgencyPublic Health Agency of Canada
KeywordsMedicinePharmacovigilanceVaccinationRashAdverse effectImmunizationPopulationPublic healthPediatricsEnvironmental healthFamily medicineImmunologyPharmacologyInternal medicine

Abstract

fetched live from OpenAlex

Background: To describe the adverse event following immunization (AEFI) reporting profile for vaccines administered in Canada during 2012 and surveillance trends relative to reports for vaccines administered from 2005 through 2011.Methods: Analysis of data based on AEFI reports received by the Public Health Agency of Canada by April 30, 2013, for vaccines marketed in Canada and administered from January 1, 2005, through December 31, 2012.Results: The AEFI reporting rate was 10.1 per 100,000 population in Canada for vaccines administered in 2012 and was inversely proportional to age.There was a trend of declining rates from 2005 (14.8) to 2012 overall and by age group.The vast majority of reports (94%-95%) were non-serious involving reactions at or near the vaccination site, rash and febrile events.Conclusion: Canada has a strong pharmacovigilance system for vaccines with one of the highest AEFI reporting rates in developed countries.Vaccines marketed in Canada have a very good safety profile.This report enables comparisons across jurisdictions in Canada and globally. Rash onlyGeneralized, localized, or location not specified Other events specified on the CAEFISS report form Arthritis Hypotonic-hyporesponsive episode (HHE) Intussusception Paraesthesia/Anaesthesia Parotitis Persistent crying Thrombocytopenia Systemic events not specified on the CAEFISS report form Fever alone Infection Influenza-like illness Other general symptom(s) Rash with fever and/or other illness Syndrome Vaccination anxiety-related events (no subtype) Miscellaneous other events Gastrointestinal disorders Vaccine failure Other events Vaccination error without an associated AEFI (no subtype)Table 2: Severity classification for primary adverse event following immunization (AEFI) in the Medical Case Review Severity Criteria Serious  Fatal outcome  Results in hospitalization or prolongation of hospitalization for ≥24 hours  Results in persistent or significant disability/incapacity  Congenital anomaly or birth defect  Life-threatening High impact  Results in hospitalization for <24 hours  Requires medically supervised observation outside of hospital  Requires ≥3 separate physician assessments during acute AEFI episode  Requires outpatient intravenous therapy (e.g., for antibiotics or rehydration)  Prevents performance of daily activities for ≥4 days Moderate impact  Results in 1-2 unscheduled urgent or non-urgent physician assessments  Requires emergency medical services to come to immunization clinic  Results in a new drug prescription or increased dose of an existing drug  Prevents performance of daily activities for 1 to 3 days Low impact  Requires treatment limited to immunization clinic setting by on-site staff  Requires health professional advice/reassurance without a scheduled visit  Requires non-prescription medication for symptomatic relief  Prevents performance of daily activities for <24 hours  No discernible impact Key definitionsAn adverse event following immunization (AEFI) is "any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine.The adverse event may be any unfavourable or unintended sign, abnormal laboratory finding, symptom or disease" (22).In 1994 the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use defined seriousness criteria for expedited reporting of AEFIs (23).A serious AEFI (SAE) is one that results in death, is life-threatening, requires in-patient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, or is a congenital anomaly/birth defect (23).Expedited reporting is defined as no later than 15 calendar days after initial recognition of the AEFI and preferably as soon as possible.At PHAC, all SAE reports are reviewed by a physician.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.049
Threshold uncertainty score0.129

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0040.005
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0110.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.086
GPT teacher head0.428
Teacher spread0.342 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2014
Admission routes4
Has abstractyes

Explore more

Same venueCanada Communicable Disease ReportSame topicPharmacovigilance and Adverse Drug ReactionsFrench-language works237,207